Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.
- Status
- COMPLETED
- Phase
- PHASE2
AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders
- Status
- COMPLETED
- Phase
- NA
Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- NA
A Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease
- Status
- COMPLETED
- Phase
- NA
Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE2
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib in Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer
- Status
- WITHDRAWN
- Phase
- NA
Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment
- Status
- COMPLETED
- Phase
- N/A
Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1